most effective area to inject tirzepatide Starting Mounjaro Tirzepatide? A Dosing & Safety Guide *BIGGEST* Weight-Loss Injection Mistakes People

NEVER CHANGE

We will send post the recorded version to the Online University within 24 hours of the broadcast Instructor: Beverly Thomassian RN, MPH, CDCES, has been Board Certified in Advanced Diabetes Management for over 20 years

Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]

After each escalation, nausea typically peaks on days 1 through 3, improves by days 4 through 5, and largely resolves by the end of the first week at the new dose

Low blood sugar is most likely in people who are also taking medications for diabetes

Hypersensitivity Anaphylaxis and angioedema have been reported